Micronoma, a San Diego company, says its technology picks up signs of very early cancer from disrupted microbiome.
Many researchers and companies are chasing the dream of detecting biomarkers of solid tumors in the blood, either to guide treatment, discover the cancer at an earlier, more treatable phase, or both. Liquid biopsies, as they are called, typically depend on finding a molecular signature of the cancer or some fragment of its DNA. Some liquid biopsy products are already approved and on the market. Read Article